CoChat

HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance

Open access

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

It is believed that the inherent tolerogenic property of the liver is involved in the chronicity of hepatitis B virus (HBV) infection [ 1 ]. However, exposure to HBV in adults usually leads to spontaneous clearance of the virus and the induction of potent and effective anti-HBV T cell immunity in the liver [ 2 ], suggesting that the immune microenvironment of the liver switches from limiting to allowing effector T cell responses during acute resolution of HBV infection. To date, it remains largely unknown how the immune microenvironment of the liver is regulated and by which mechanism a favorable intrahepatic anti-HBV T cell response is generated in an infected individual. Liver sinusoidal endothelial cells (LSECs) play key roles in intrahepatic immune surveillance against infection by regulating the activation of local immune cells [ 3 ]. We have previously demonstrated that LSECs switch from a tolerogenic to an immunogenic state and trigger cytotoxic effector CD8 T cell activation under inflammatory conditions [ 4 , 5 ]. Here, we investigated whether LSECs exhibit plasticity and switch from a tolerogenic to an immunogenic state upon HBV exposure. We first analyzed LSEC-mediated T cell suppression during the course of acute resolution of HBV replication using the HBV hydrodynamic injection (HDI) mouse model. LSECs were freshly purified at 14 days post injection (dpi) and cocultured with T cell receptor (TCR)-activated T cells (Fig. 1A ). These T cells produced significantly higher levels of IFNγ than those cocultured with control LSECs (Fig. 1A ). LSECs from HBV HDI mice also showed less suppression of CD8 T cell proliferation than LSECs from control mice (Fig. 1A ). These results suggest that the ability of LSECs to suppress T cell activation was abolished in HBV HDI mice at 14 dpi. Next, we examined whether exposure to specific HBV antigens altered the ability of LSECs to suppress T cell activation. Our data showed that in vitro pretreatment of LSECs with recombinant HBeAg (rHBeAg) completely abolished the suppression of T cell IFNγ production in a dose-dependent manner (Fig. 1B ). Activated T cells cocultured with LSECs exposed to HBeAg in vivo also showed significantly increased IFNγ production compared with those cocultured with control LSECs (Fig. 1B ). Moreover, CD3/CD28 Dynabead-activated human PBMCs cocultured with rHBeAg-pretreated human LSECs produced significantly higher amounts of IFNγ than PBMCs cultured with control LSECs (Fig. 1B ). These data suggest that HBeAg stimulation could abrogate LSEC-mediated T cell suppression in both mice and humans. Fig. 1: HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. A LSECs from mice that were hydrodynamically injected with pSM2 plasmid (HBV) or PBS (HDI Ctrl) were isolated 14 days postinjection (dpi) and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2 (LSECs: splenocytes). Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). IFNγ production was measured after 48 h. CFSE-labeled polyclonally stimulated splenocytes were cocultured with LSECs, and after 72 h, CD8 T cell proliferation was analyzed by flow cytometry. B Naïve mouse or primary human LSECs were treated with recombinant HBeAg (rHBeAg) or left untreated (Ctrl) for 24 h, washed and cocultured with polyclonally stimulated splenocytes or PBMCs at a ratio of 1:2. LSECs from mice that were hydrodynamically injected with pcDNA3.1/HBeAg or the pcDNA3.1/null plasmid at 2 dpi were isolated and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2. IFNγ production was measured after 48 h. Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). C LSECs from naïve mice were mock-treated or treated with rHBeAg, and total RNA was extracted from the cells 6 h later for RNA-seq analysis. Log2-fold changes in the top 20 differentially expressed genes (DEGs), KEGG pathway enrichment analysis and gene set enrichment analysis (GSEA), as determined by RNA-seq analysis. D Supernatants of rHBeAg-LSECs or HBV-LSECs were analyzed for TNF α and IL-27. E Polyclonally stimulated splenocytes were cocultured with rHBeAg-LSECs or HBV-LSECs, and then 10 μg/ml anti–IL-27 Abs (aIL-27) or anti–TNFα Abs (aTNFα) were added to the cocultures, with untreated cocultures as the control (Ctrl). IFNγ production was measured by ELISA after 48 h. F Polyclonally stimulated splenocytes were cocultured with LSECs from naïve mice, and 50 ng/ml rIL-27 or 100 ng/ml rTNFα was added to the cocultures. IFNγ production was measured by ELISA after 48 h. Anti-CD3/anti-CD28-stimulated splenocytes only were used as a responder controls (RC). Unstimulated splenocytes were used as a negative control (NC). Unpaired t -test or one-way ANOVA is used. Error bars, mean ± SEM; *

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41423-021-00769-7

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. A LSECs from mice that were hydrodynamically injected with pSM2 plasmid (HBV) or PBS (HDI Ctrl) were isolated 14 days postinjection (dpi) and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2 (LSECs: splenocytes). Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). IFNγ production was measured after 48 h. CFSE-labeled polyclonally stimulated splenocytes were cocultured with LSECs, and after 72 h, CD8 T cell proliferation was analyzed by flow cytometry. B Naïve mouse or primary human LSECs were treated with recombinant HBeAg (rHBeAg) or left untreated (Ctrl) for 24 h, washed and cocultured with polyclonally stimulated splenocytes or PBMCs at a ratio of 1:2. LSECs from mice that were hydrodynamically injected with pcDNA3.1/HBeAg or the pcDNA3.1/null plasmid at 2 dpi were isolated and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2. IFNγ production was measured after 48 h. Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). C LSECs from naïve mice were mock-treated or treated with rHBeAg, and total RNA was extracted from the cells 6 h later for RNA-seq analysis. Log2-fold changes in the top 20 differentially expressed genes (DEGs), KEGG pathway enrichment analysis and gene set enrichment analysis (GSEA), as determined by RNA-seq analysis. D Supernatants of rHBeAg-LSECs or HBV-LSECs were analyzed for TNF α and IL-27. E Polyclonally stimulated splenocytes were cocultured with rHBeAg-LSECs or HBV-LSECs, and then 10 μg/ml anti–IL-27 Abs (aIL-27) or anti–TNFα Abs (aTNFα) were added to the cocultures, with untreated cocultures as the control (Ctrl). IFNγ production was measured by ELISA after 48 h. F Polyclonally stimulated splenocytes were cocultured with LSECs from naïve mice, and 50 ng/ml rIL-27 or 100 ng/ml rTNFα was added to the cocultures. IFNγ production was measured by ELISA after 48 h. Anti-CD3/anti-CD28-stimulated splenocytes only were used as a responder controls (RC). Unstimulated splenocytes were used as a negative control (NC). Unpaired t-test or one-way ANOVA is used. Error bars, mean ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001.
Fig. 1 HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. A LSECs from mice that were hydrodynamically injected with pSM2 plasmid (HBV) or PBS (HDI Ctrl) were isolated 14 days postinjection (dpi) and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2 (LSECs: splenocytes). Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). IFNγ production was measured after 48 h. CFSE-labeled polyclonally stimulated splenocytes were cocultured with LSECs, and after 72 h, CD8 T cell proliferation was analyzed by flow cytometry. B Naïve mouse or primary human LSECs were treated with recombinant HBeAg (rHBeAg) or left untreated (Ctrl) for 24 h, washed and cocultured with polyclonally stimulated splenocytes or PBMCs at a ratio of 1:2. LSECs from mice that were hydrodynamically injected with pcDNA3.1/HBeAg or the pcDNA3.1/null plasmid at 2 dpi were isolated and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2. IFNγ production was measured after 48 h. Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). C LSECs from naïve mice were mock-treated or treated with rHBeAg, and total RNA was extracted from the cells 6 h later for RNA-seq analysis. Log2-fold changes in the top 20 differentially expressed genes (DEGs), KEGG pathway enrichment analysis and gene set enrichment analysis (GSEA), as determined by RNA-seq analysis. D Supernatants of rHBeAg-LSECs or HBV-LSECs were analyzed for TNF α and IL-27. E Polyclonally stimulated splenocytes were cocultured with rHBeAg-LSECs or HBV-LSECs, and then 10 μg/ml anti–IL-27 Abs (aIL-27) or anti–TNFα Abs (aTNFα) were added to the cocultures, with untreated cocultures as the control (Ctrl). IFNγ production was measured by ELISA after 48 h. F Polyclonally stimulated splenocytes were cocultured with LSECs from naïve mice, and 50 ng/ml rIL-27 or 100 ng/ml rTNFα was added to the cocultures. IFNγ production was measured by ELISA after 48 h. Anti-CD3/anti-CD28-stimulated splenocytes only were used as a responder controls (RC). Unstimulated splenocytes were used as a negative control (NC). Unpaired t-test or one-way ANOVA is used. Error bars, mean ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 11

Metadata

Authors
Xie, X., Luo, J., Broering, R., Zhu, D., Zhou, W., Lu, M., Zheng, X., Dittmer, U., Yang, D., & Liu, J.
Affiliations
  • Wuhan Union Hospital (CN)
  • Essen University Hospital (DE)
Corresponding author
Liu, Jia
Venue
Cellular & Molecular Immunology
Published
2021-09-15
Volume
18
Issue
11
Pages
2572-2574
ISSN
  • 1672-7681 (ISSN-L)
  • 2042-0226
OpenAlex
W3200080649
Cited by
11
References
5
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3
FWCI
1.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81861138044, 91742114, 2017ZX10202203, 91642118)
  • Tongji University
Topics
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Keywords
hepatitis B virus, HBeAg, liver sinusoidal endothelial cells, CD8+ T cell immunity, HBV clearance, T cell tolerance, T cell suppression, interferon-gamma, liver immune microenvironment, chronic hepatitis B, T cell activation, endothelial plasticity
MeSH terms
Cell Plasticity, Animals, Cytotoxicity, Immunologic, Disease Models, Animal, Hepatitis B e Antigens, Hepatitis B virus, Humans, Immune Tolerance, Liver, CD8-Positive T-Lymphocytes, Hepatitis B, Chronic, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. https://app.cochat.ai/papers/10.1038/s41423-021-00769-7
The paper
Xie, X., Luo, J., Broering, R., Zhu, D., Zhou, W., Lu, M., Zheng, X., Dittmer, U., Yang, D., & Liu, J. (2021). HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-021-00769-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.